Arteriosclerosis, Vol 8, 368-377, Copyright © 1988 by American Heart Association
ARTICLES |
G Camejo, SO Olofsson, F Lopez, P Carlsson and G Bondjers
Instituto Venezolano de Investigaciones Cientificas, Centro de Biofisica y Bioquimica, Caracas, Venezuela.
The interactions of low density lipoprotein (LDL) and apolipoprotein (apo) B-100 segments with chondroitin-6-SO4 rich aortic proteoglycans aggregate (CSPG) were studied by using quantitative frontal elution affinity chromatography. The affinity of the agarose-CSPG was higher for LDL than for very low density lipoprotein and high density lipoprotein was not bound. LDL from different individuals had dissociation coefficients (Kd) from 28 to 179 nM. Experiments with tryptic hydrolysates of apo B suggested that the capacity of LDL to bind with CSPG resides in the protein. Nine apo B-100 hydrophilic peptides, 12 to 26 amino acids long, were selected, and three were found to interact with the agarose-bound CSPG: apo B P-1 (LRKHKLIDVISMYRELLKDLSKEA, residues 4230 to 4254), apo B P-2 (RLTRKRGLKLATALSLSNK, residues 3359 to 3377), and apo B P-11 (RQVSHAKEKLTALTKK, residues 2106 to 2121). These peptides competed with LDL for binding to the agarose-bound and soluble CSPG; apo B P-2 was the most effective. This correlates with Kd values: 63, 86, and 82 microM for apo B P-2, P-1, and P-11, respectively. The peptides shared an excess of positive-charged side chains. Apo B P-2 belongs to the lys- and arg-rich, LDL-receptor domain. Apo E also binds to the agarose- proteoglycan. The results suggest that apo B regions with sequences and charge distributions analogous to those of residues 3359 to 3377, 4230 to 4254, and 2106 and 2121 are among those responsible for the interaction of LDL with intima-media CSPG.
This article has been cited by other articles:
![]() |
C. Bancells, S. Benitez, M. Jauhiainen, J. Ordonez-Llanos, P. T. Kovanen, S. Villegas, J. L. Sanchez-Quesada, and K. Oorni High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level J. Lipid Res., March 1, 2009; 50(3): 446 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M McMahon, J Grossman, W Chen, and B H Hahn Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus Lupus, November 1, 2006; 15(11_suppl): 59 - 69. [Abstract] [PDF] |
||||
![]() |
M. F. Khalil, W. D. Wagner, and I. J. Goldberg Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2211 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Vikramadithyan, Y. Kako, G. Chen, Y. Hu, E. Arikawa-Hirasawa, Y. Yamada, and I. J. Goldberg Atherosclerosis in perlecan heterozygous mice J. Lipid Res., October 1, 2004; 45(10): 1806 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Flood, M. Gustafsson, R. E. Pitas, L. Arnaboldi, R. L. Walzem, and J. Boren Molecular Mechanism for Changes in Proteoglycan Binding on Compositional Changes of the Core and the Surface of Low-Density Lipoprotein-Containing Human Apolipoprotein B100 Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 564 - 570. [Abstract] [Full Text] |
||||
![]() |
K. Olin-Lewis, R. M. Krauss, M. La Belle, P. J. Blanche, P. H. R. Barrett, T. N. Wight, and A. Chait ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan J. Lipid Res., November 1, 2002; 43(11): 1969 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Flood, M. Gustafsson, P. E. Richardson, S. C. Harvey, J. P. Segrest, and J. Boren Identification of the Proteoglycan Binding Site in Apolipoprotein B48 J. Biol. Chem., August 23, 2002; 277(35): 32228 - 32233. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Olin-Lewis, J. L. Benton, J. C. Rutledge, D. G. Baskin, T. N. Wight, and A. Chait Apolipoprotein E Mediates the Retention of High-Density Lipoproteins by Mouse Carotid Arteries and Cultured Arterial Smooth Muscle Cell Extracellular Matrices Circ. Res., June 28, 2002; 90(12): 1333 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Llorente-Cortes, M. Otero-Vinas, E. Hurt-Camejo, J. Martinez-Gonzalez, and L. Badimon Human Coronary Smooth Muscle Cells Internalize Versican-Modified LDL Through LDL Receptor-Related Protein and LDL Receptors Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 387 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nilsson, M.P.S. Ares, M. Lindholm, G.N. Fredriksonl, and S. Jovinge Inflammation and cholesterol Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A18 - A25. [Abstract] [PDF] |
||||
![]() |
K. L. Olin, S. Potter-Perigo, P. H. R. Barrett, T. N. Wight, and A. Chait Biglycan, a Vascular Proteoglycan, Binds Differently to HDL2 and HDL3 : Role of ApoE Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 129 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Öörni, M. O. Pentikäinen, M. Ala-Korpela, and P. T. Kovanen Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions J. Lipid Res., November 1, 2000; 41(11): 1703 - 1714. [Abstract] [Full Text] |
||||
![]() |
A. A.-R. Higazi, T. Nassar, T. Ganz, D. J. Rader, R. Udassin, K. Bdeir, E. Hiss, B. S. Sachais, K. J. Williams, E. Leitersdorf, et al. The alpha -defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis Blood, August 15, 2000; 96(4): 1393 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Olin, S. Potter-Perigo, P. H. R. Barrett, T. N. Wight, and A. Chait Lipoprotein Lipase Enhances the Binding of Native and Oxidized Low Density Lipoproteins to Versican and Biglycan Synthesized by Cultured Arterial Smooth Muscle Cells J. Biol. Chem., December 3, 1999; 274(49): 34629 - 34636. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Goldberg, W. D. Wagner, L. Pang, L. Paka, L. K. Curtiss, J. A. DeLozier, G. S. Shelness, C. S. H. Young, and S. Pillarisetti The NH2-terminal Region of Apolipoprotein B Is Sufficient for Lipoprotein Association with Glycosaminoglycans J. Biol. Chem., December 25, 1998; 273(52): 35355 - 35361. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sartipy, G. Bondjers, and E. Hurt-Camejo Phospholipase A2 Type II Binds to Extracellular Matrix Biglycan : Modulation of Its Activity on LDL by Colocalization in Glycosaminoglycan Matrixes Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1934 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Oorni, J. K. Hakala, A. Annila, M. Ala-Korpela, and P. T. Kovanen Sphingomyelinase Induces Aggregation and Fusion, but Phospholipase A2 Only Aggregation, of Low Density Lipoprotein (LDL) Particles. TWO DISTINCT MECHANISMS LEADING TO INCREASED BINDING STRENGTH OF LDL TO HUMAN AORTIC PROTEOGLYCANS J. Biol. Chem., October 30, 1998; 273(44): 29127 - 29134. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Calara, P. Dimayuga, A. Niemann, J. Thyberg, U. Diczfalusy, J. L. Witztum, W. Palinski, P. K. Shah, B. Cercek, J. Nilsson, et al. An Animal Model to Study Local Oxidation of LDL and Its Biological Effects in the Arterial Wall Arterioscler Thromb Vasc Biol, June 1, 1998; 18(6): 884 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Camejo, C. Halberg, A. Manschik-Lundin, E. Hurt-Camejo, B. Rosengren, H. Olsson, G. I. Hansson, G.-B. Forsberg, and B. Ylhen Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages J. Lipid Res., April 1, 1998; 39(4): 755 - 766. [Abstract] [Full Text] |
||||
![]() |
M. Kaplan, K. J. Williams, H. Mandel, and M. Aviram Role of Macrophage Glycosaminoglycans in the Cellular Catabolism of Oxidized LDL by Macrophages Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 542 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Oorni, M. O. Pentikainen, A. Annila, and P. T. Kovanen Oxidation of Low Density Lipoprotein Particles Decreases Their Ability to Bind to Human Aortic Proteoglycans. DEPENDENCE ON OXIDATIVE MODIFICATION OF THE LYSINE RESIDUES J. Biol. Chem., August 22, 1997; 272(34): 21303 - 21311. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hurt-Camejo, U. Olsson, O. Wiklund, G. Bondjers, and G. Camejo Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans: Potential Contribution to Atherogenesis Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1011 - 1017. [Abstract] [Full Text] |
||||
![]() |
U. Olsson, G. Camejo, E. Hurt-Camejo, K. Elfsber, O. Wiklund, and G. Bondjers Possible Functional Interactions of Apolipoprotein B-100 Segments That Associate With Cell Proteoglycans and the ApoB/E Receptor Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 149 - 155. [Abstract] [Full Text] |
||||
![]() |
P. Sartipy, B. Johansen, G. Camejo, B. Rosengren, G. Bondjers, and E. Hurt-Camejo Binding of Human Phospholipase A2 Type II to Proteoglycans. DIFFERENTIAL EFFECT OF GLYCOSAMINOGLYCANS ON ENZYME ACTIVITY J. Biol. Chem., October 18, 1996; 271(42): 26307 - 26314. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Navab, J. A. Berliner, A. D. Watson, S. Y. Hama, M. C. Territo, A. J. Lusis, D. M. Shih, B. J. Van Lenten, J. S. Frank, L. L. Demer, et al. The Yin and Yang of Oxidation in the Development of the Fatty Streak: A Review Based on the 1994 George Lyman Duff Memorial Lecture Arterioscler Thromb Vasc Biol, July 1, 1996; 16(7): 831 - 842. [Abstract] [Full Text] |
||||
![]() |
M. Kaartinen, A. Penttila, and P. T. Kovanen Extracellular Mast Cell Granules Carry Apolipoprotein B-100–Containing Lipoproteins Into Phagocytes in Human Arterial Intima : Functional Coupling of Exocytosis and Phagocytosis in Neighboring Cells Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 2047 - 2054. [Abstract] [Full Text] |
||||
![]() |
E. H. Camejo, B. Rosengren, G. Camejo, P. Sartipy, G. Fager, and G. Bondjers Interferon Gamma Binds to Extracellular Matrix Chondroitin-Sulfate Proteoglycans, Thus Enhancing Its Cellular Response Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1456 - 1465. [Abstract] [Full Text] |
||||
![]() |
H. C. Stary, A. B. Chandler, R. E. Dinsmore, V. Fuster, S. Glagov, W. Insull Jr, M. E. Rosenfeld, C. J. Schwartz, W. D. Wagner, and R. W. Wissler A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1512 - 1531. [Abstract] [Full Text] |
||||
![]() |
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien The Intima : Soil for Atherosclerosis and Restenosis Circ. Res., September 1, 1995; 77(3): 445 - 465. [Full Text] |
||||
![]() |
H. C. Stary, A. B. Chandler, R. E. Dinsmore, V. Fuster, S. Glagov, W. Insull Jr, M. E. Rosenfeld, C. J. Schwartz, W. D. Wagner, and R. W. Wissler A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation, September 1, 1995; 92(5): 1355 - 1374. [Abstract] [Full Text] |
||||
![]() |
G. Olsson, O. Wiklund, and G. Bondjers Effects of Injury on ApoB Kinetics and Concentration in Rabbit Aorta Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 930 - 936. [Abstract] [Full Text] |
||||
![]() |
K. Paananen, J. Saarinen, A. Annila, and P. T. Kovanen Proteolysis and Fusion of Low Density Lipoprotein Particles Strengthen Their Binding to Human Aortic Proteoglycans J. Biol. Chem., May 19, 1995; 270(20): 12257 - 12262. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Williams and I. Tabas The Response-to-Retention Hypothesis of Early Atherogenesis Arterioscler Thromb Vasc Biol, May 1, 1995; 15(5): 551 - 561. [Full Text] |
||||
![]() |
T. A. Ramsamy, T. A.-M. Neville, B. M. Chauhan, D. Aggarwal, and D. L. Sparks Apolipoprotein A-I Regulates Lipid Hydrolysis by Hepatic Lipase J. Biol. Chem., October 20, 2000; 275(43): 33480 - 33486. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |